RDW and RV-PA Coupling in Acute PE

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

Prior work linking RDW to echocardiographic findings in PE has largely focused on isolated parameters such as TAPSE or PASP and has rarely incorporated modern measures of RV-PA coupling. Whether admission RDW reflects the integrated RV-PA interaction - and not merely contractility or pressure in isolation - has not been adequately addressed. Establishing this link would support RDW as a simple, universally available marker of RV vulnerability at first presentation, and would lay the groundwork for future prognostic and mechanistic studies.

Eligibility criteria

Qualifiers

None

Disqualifiers

Active hematologic malignancy or recent chemotherapy with myelosuppressive intent.

Red blood cell transfusion within the preceding 90 days.

Known hemoglobinopathy (e.g., sickle cell disease, thalassemia major).

Chronic dialysis or eGFR < 15 mL/min/1.73 m².

Trial design

Treatments tested in this trial

  • Echo-cardiography

Treatment groups

190 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators